NEA Management Company as of Sept. 30, 2014
Portfolio Holdings for NEA Management Company
NEA Management Company holds 35 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Groupon | 18.4 | $363M | 54M | 6.68 | |
| Tesaro | 13.5 | $265M | 9.9M | 26.92 | |
| Opower | 8.6 | $170M | 9.0M | 18.86 | |
| Epizyme | 7.1 | $140M | 5.1M | 27.11 | |
| Cvent | 6.4 | $127M | 5.0M | 25.37 | |
| Clovis Oncology | 5.3 | $103M | 2.3M | 45.36 | |
| Ardelyx (ARDX) | 4.8 | $94M | 6.6M | 14.21 | |
| Supernus Pharmaceuticals (SUPN) | 4.7 | $93M | 11M | 8.69 | |
| Hyperion Therapeutics | 3.1 | $60M | 2.4M | 25.22 | |
| Glycomimetics (GLYC) | 3.0 | $60M | 8.6M | 6.94 | |
| Trivascular Technologies | 2.9 | $57M | 3.9M | 14.48 | |
| Prosensa Hldgs B V Shs Usd | 2.8 | $55M | 6.5M | 8.43 | |
| Aerohive Networks | 2.0 | $39M | 4.9M | 8.02 | |
| Amicus Therapeutics (FOLD) | 1.7 | $34M | 5.7M | 5.95 | |
| Sunesis Pharmaceuticals | 1.7 | $33M | 4.7M | 7.14 | |
| Roka Bioscience | 1.6 | $32M | 3.2M | 10.05 | |
| Boingo Wireless | 1.6 | $32M | 4.5M | 7.13 | |
| Care | 1.4 | $27M | 3.3M | 8.15 | |
| Trevena | 1.2 | $25M | 3.8M | 6.42 | |
| Nektar Therapeutics (NKTR) | 1.1 | $22M | 1.8M | 12.07 | |
| Vitae Pharmaceuticals | 1.0 | $20M | 2.6M | 7.63 | |
| Lexicon Pharmaceuticals | 0.8 | $17M | 12M | 1.41 | |
| Orexigen Therapeutics | 0.8 | $16M | 3.7M | 4.26 | |
| Millennial Media | 0.8 | $15M | 8.2M | 1.86 | |
| Zhone Technologies | 0.7 | $13M | 4.8M | 2.70 | |
| Alimera Sciences Comstkusd0.01 | 0.6 | $12M | 2.3M | 5.42 | |
| Targacept | 0.6 | $12M | 4.6M | 2.53 | |
| Channeladvisor | 0.5 | $9.1M | 557k | 16.40 | |
| Aurinia Pharmaceuticals (AUPH) | 0.4 | $8.1M | 2.5M | 3.20 | |
| Rigel Pharmaceuticals | 0.3 | $6.3M | 3.2M | 1.94 | |
| Transcept Pharmaceuticals | 0.2 | $4.2M | 2.1M | 2.03 | |
| Exelixis (EXEL) | 0.2 | $3.4M | 2.2M | 1.53 | |
| ArQule | 0.1 | $2.8M | 2.5M | 1.12 | |
| NeuroMetrix | 0.0 | $103k | 57k | 1.80 | |
| Agile Therapeutics | 0.0 | $218k | 30k | 7.30 |
